In this study, we found that CPC significantly inhibited the EMT of HCC cells by decreasing Slug expression, thereby promoting the expression of E-cadherin and inhibiting the expression of N-cadherin and vimentin in vivo and in vitro, suggesting that CPC is a potential agent for the treatment of HCC metastasis. The gene discussed is SNAI2; the disease is hepatocellular carcinoma.